162 — Waldorf, Maryland

162 is a clinical research site located in Waldorf, Maryland, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

162 has participated in 1 clinical trials.

Therapeutic areas: Partial Epilepsies.

Sponsors: UCB Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 162?

162 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 162 conducted?

162 has 1 clinical trials on record. Their work covers Partial Epilepsies.

Is 162 accredited by Crixeo Health?

162 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 162?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.